Suppr超能文献

Dose ranging study and constant infusion evaluation of ciprofloxacin.

作者信息

Drusano G L, Plaisance K I, Forrest A, Standiford H C

出版信息

Antimicrob Agents Chemother. 1986 Sep;30(3):440-3. doi: 10.1128/AAC.30.3.440.

Abstract

We evaluated the pharmacokinetics of 100- and 200-mg doses of ciprofloxacin, with the 200-mg dose administered either as a 30-min infusion or as a 100-mg loading dose followed by a 4-h constant infusion of 25 mg/h in six normal volunteers. No significant differences were seen in the dose-normalized area under the curve when the 100- and 200-mg 30-min administrations were compared. Differences that approached statistical significance were seen when data from either of these trials were compared with data from the constant-infusion arm. Serum clearances averaged 23.0 +/- 9.1 liters/h per 1.73 m2 for the 100-mg dose and 23.7 +/- 5.1 liters/h per 1.73 m2 for the 200-mg dose. Renal clearance accounted for approximately two-thirds of the serum clearance in each instance. Half-lives were slightly longer than 4 h. For the constant-infusion arm, serum clearance was 28.9 +/- 2.7 liters/h per 1.73 m2, with renal clearance accounting for 58% of serum clearance. Although no nonlinearities were apparent in the 100- to 200-mg dose range, larger doses, particularly in the multiple-dosing situation, may uncover nonlinearity in the disposition of ciprofloxacin.

摘要

相似文献

1
Dose ranging study and constant infusion evaluation of ciprofloxacin.
Antimicrob Agents Chemother. 1986 Sep;30(3):440-3. doi: 10.1128/AAC.30.3.440.
2
Absolute oral bioavailability of ciprofloxacin.
Antimicrob Agents Chemother. 1986 Sep;30(3):444-6. doi: 10.1128/AAC.30.3.444.
3
Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function.
Antimicrob Agents Chemother. 1987 Jun;31(6):860-4. doi: 10.1128/AAC.31.6.860.
4
Multiple-dose pharmacokinetics of ciprofloxacin administered intravenously to normal volunteers.
Antimicrob Agents Chemother. 1985 Aug;28(2):235-9. doi: 10.1128/AAC.28.2.235.
6
Dose-ranging pharmacokinetic study of ciprofloxacin after 200-, 300-, and 400-mg intravenous doses.
Ann Pharmacother. 1992 Jan;26(1):8-10. doi: 10.1177/106002809202600101.
7
Effects of cardiopulmonary bypass surgery on intravenous ciprofloxacin disposition.
Antimicrob Agents Chemother. 1993 Oct;37(10):2106-11. doi: 10.1128/AAC.37.10.2106.
8
Relationships between renal function and disposition of oral ciprofloxacin.
Antimicrob Agents Chemother. 1988 Oct;32(10):1537-40. doi: 10.1128/AAC.32.10.1537.
9
Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses.
Antimicrob Agents Chemother. 1992 May;36(5):993-6. doi: 10.1128/AAC.36.5.993.
10
Pharmacokinetics of ciprofloxacin in cystic fibrosis.
Antimicrob Agents Chemother. 1987 Jun;31(6):915-9. doi: 10.1128/AAC.31.6.915.

引用本文的文献

2
3
Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials.
Clin Pharmacokinet. 2001;40(3):169-87. doi: 10.2165/00003088-200140030-00003.
4
Pharmacokinetics of ciprofloxacin in the human eye: a clinical study and population pharmacokinetic analysis.
Antimicrob Agents Chemother. 2000 Jun;44(6):1674-9. doi: 10.1128/AAC.44.6.1674-1679.2000.
5
The pharmacokinetic principles behind scaling from preclinical results to phase I protocols.
Clin Pharmacokinet. 1999 Jan;36(1):1-11. doi: 10.2165/00003088-199936010-00001.
6
Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin.
Antimicrob Agents Chemother. 1993 May;37(5):1065-72. doi: 10.1128/AAC.37.5.1065.
7
Clinical pharmacokinetics of sparfloxacin.
Clin Pharmacokinet. 1993 Nov;25(5):358-69. doi: 10.2165/00003088-199325050-00002.
8
Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function.
Antimicrob Agents Chemother. 1987 Jun;31(6):860-4. doi: 10.1128/AAC.31.6.860.
9
Comparative pharmacokinetics of new quinolones.
Drugs. 1987;34 Suppl 1:21-5. doi: 10.2165/00003495-198700341-00006.
10
Pharmacokinetics of ofloxacin after parenteral and oral administration.
Antimicrob Agents Chemother. 1987 Sep;31(9):1338-42. doi: 10.1128/AAC.31.9.1338.

本文引用的文献

1
In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.
Antimicrob Agents Chemother. 1984 Mar;25(3):331-5. doi: 10.1128/AAC.25.3.331.
2
A program package for simulation and parameter estimation in pharmacokinetic systems.
Comput Programs Biomed. 1979 Mar;9(2):115-34. doi: 10.1016/0010-468x(79)90025-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验